Posts tagged cannabinoid
Leerink starts Arena Pharma at OP

Leerink initiated coverage of Arena Pharmaceuticals (NASDAQ:ARNA) with an “outperform” rating and $5 price target. The stock closed at $1.15 on May 18.

Read More
IntelGenx, Tetra to develop Dronabinol XL tablet

IntelGenx (OTCQX:IGXT; TSXV:IGX) and Tetra Bio-Pharma (CSE:TBP; OTC:GRPOF) signed a definitive agreement to develop and commercialize a drug product containing the cannabinoid, Dronabinol, for the management of anorexia and cancer chemotherapy-related pain.

Read More